id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0007-0010,FDA,FDA-2002-P-0007,Attachment 2  Cefuroxime Axetil Tablets for Oral Suspension [The Weinberg Group Inc. CP 1],Supporting & Related Material,Background Material,2011-01-14T05:00:00Z,2011,1,,,2024-08-26T18:47:34Z,,0,0,0900006480487413
FDA-2002-P-0007-0009,FDA,FDA-2002-P-0007,Citizens Petition from The Weinberg Group Inc.,Other,CP-Citizen Petition,2011-01-14T05:00:00Z,2011,1,2011-01-14T05:00:00Z,,2024-08-26T18:30:04Z,,0,0,0900006480487421
FDA-2002-P-0007-0011,FDA,FDA-2002-P-0007,Petition for Reconsideration from The Weinberg Group Inc.,Other,PRC-Petition for Reconsideration,2011-01-14T05:00:00Z,2011,1,2011-01-14T05:00:00Z,,2024-08-26T18:31:23Z,,0,0,090000648048742a